Search results
Lack of insurance keeps many Americans from best cancer meds
Medical Xpress· 21 hours agoThe study was led by ACS researcher Dr. Jingxuan Zhao. ICIs include such blockbuster cancer...
Lack of insurance may prevent Americans from accessing best cancer drugs
UPI· 18 hours agoAmong patients diagnosed with advanced melanomas, those who had private health insurance saw rates...
AstraZeneca immunotherapy extends survival by two years in rarer type of lung cancer
BioPharma Dive via Yahoo Finance· 2 days agoIn that setting, Imfinzi competes with Roche’s immunotherapy Tecentriq. Amgen’s new dual-acting drug...
A Deeper Look at Anti-PD-1/PD-L1 Checkpoint Inhibitors for Cancer
Forbes· 4 days agoIn a previous story, I described pembrolizumab, a PD-1 targeting checkpoint inhibitor, in some...
BMS secures another EC approval for Opdivo combination
Pharmaceutical Technology via Yahoo Finance· 6 days agoAccording to GlobalData, there are currently six marketed therapies for the treatment of urothelial...
Exelixis (EXEL) Down 6.6% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 5 days agoThe company is evaluating the combination of cabozantinib and Tecentriq (atezolizumab) versus a...
Biotech Sector Working to Combat Rising Cases of Colorectal Cancer in Young Adults
WROC Rochester· 7 days agoUSA News Group – Rates of cancer of the colorectal and anal regions have been on the rise for years...